HOME >> MEDICINE >> NEWS
Treatment interruption shows no benefit in drug-resistant HIV infection

Prescribed interruptions in antiretroviral therapy--so-called "drug holidays"--may hasten disease progression in a subset of HIV-infected individuals, namely those whose treatment has been rendered significantly less effective by the development of resistance to multiple anti-HIV drugs (MDR-HIV). This was the finding in a study by researchers supported by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health (NIH).

As reported in the August 28, 2003 issue of The New England Journal of Medicine, researchers found that study participants who underwent a four-month structured treatment interruption had more HIV-related complications and poorer immune response than did individuals who took antiretroviral drugs continuously throughout the study.

"Interruption of treatment has become increasingly common among HIV-infected individuals," says NIAID Director Anthony S. Fauci, M.D. "This study helps to clarify the effects of treatment interruption in one group of patients and emphasizes how important it is for people to join clinical trials to help answer questions that will improve patient care."

As used in this study, structured treatment interruption involves discontinuing all anti-HIV drugs for a defined period of time to allow the repopulating virus to regain susceptibility to anti-HIV drugs. Previous studies of individuals infected with MDR-HIV have shown that drug-sensitive variants of the virus re-emerge and become predominant after therapy is stopped. Treatment interruptions have also been used to give people time off from multiple medications that may be difficult to take and have toxic side effects.

"We had hoped that a structured treatment interruption would be beneficial for people experiencing treatment failure due to multidrug-resistant HIV," says study chair Jody Lawrence, M.D., of the Department of Medicine at the University of California, San Francisco. "However, our resul
'"/>

Contact: John Bowersox
jbowersox@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
27-Aug-2003


Page: 1 2 3

Related medicine news :

1. Treatment of cardiac lesions without anaesthesic
2. Treatment guidelines for kids with bipolar disorder published
3. University of Washington joins new Autism Treatment Network to provide better medical services
4. Treatment for brain tumor does not always follow recommendations
5. Advances in Skeletal Anabolic Agents for the Treatment of Osteoporosis: A scientific meeting
6. Treatment of ductal carcinoma in situ varies widely in United States
7. Treatment options expand for patients with neuropathic pain
8. Peanut Allergy: Major Advances in Treatment and Education
9. Release of results of Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
10. Treatment helped reduce dose of inhaled corticosteroids while maintaining asthma control
11. Treatment for behavioral disorders in children with autism

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2019)... (PRWEB) , ... December 05, 2019 , ... ... with milestones ranging from launching exceptional products that help people embrace, achieve, and ... world. , “We’ve never been more committed to our mission of impacting world ...
(Date:12/4/2019)... ... December 04, 2019 , ... A November 12 ... cities offer them as public transit options. The article highlighted the life-changing or life-ending ... confined to a bed to a rider fatality after an incident with a vehicle. ...
(Date:12/4/2019)... ... 04, 2019 , ... WEDI , the nation’s leading nonprofit authority on ... a trusted advisor to the U.S. Department of Health and Human Services (HHS), announced ... the 2019 WEDI Winter Conference in Arlington, Va. on Wednesday, December 4. , “The ...
(Date:12/4/2019)... ... December 04, 2019 , ... While the holidays are a time for ... said Texas A&M AgriLife Extension Service specialists. , “There are many ... benefit your overall wellness,” said Joyce Cavanagh, AgriLife Extension specialist in family economics, College ...
(Date:12/4/2019)... YORK (PRWEB) , ... December 04, 2019 , ... ... Phase I study of AZD4041 for treating tobacco use and dependence. The study ... a central nervous system (CNS) penetrant antagonist of orexin-1 (hypocretin-1) receptors that is ...
Breaking Medicine News(10 mins):
(Date:12/6/2019)... ... December 06, 2019 , ... Kindred ... expansion in services. While Kindred Nutrition and Wellness will continue to focus ... now happy to offer Individual and Family Therapy and Yoga. , Kindred Nutrition ...
(Date:12/5/2019)... ... , ... Intelligent.com, a trusted resource for online degree rankings ... for 2020. The comprehensive research guide is based on an assessment of 67 ... curriculum quality, graduation rate, reputation, and post-graduate employment. , The 2020 rankings ...
(Date:12/4/2019)... ST. LOUIS (PRWEB) , ... ... ... healthcare industry leader in delivering solutions designed for improved financial, operational and ... Officer, has earned the Fellow designation from the American College of Healthcare ...
Breaking Medicine Technology:
Cached News: